Position in AMGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,537,550
+$202,364 QoQ
Shares Held
9,769
+3.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#990
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HBK Sorce Advisory LLC holds $60,692,879 across 13 Drug Manufacturers - General names. AMGN ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,310 | $20,762,135 | |
| 2 | JNJ |
Johnson & Johnson
|
44,818 | $11,382,427 | |
| 3 | MRK |
Merck & Co., Inc.
|
54,037 | $6,943,754 | |
| 4 | ABBV |
AbbVie Inc.
|
20,828 | $5,241,157 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
30,439 | $3,845,663 | |
| 6 | PFE |
Pfizer Inc
|
157,717 | $3,797,825 | |
| 7 | AMGN |
Amgen Inc
This page
|
9,769 | $3,537,550 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
40,142 | $2,312,982 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,537,550 | 9,769 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $3,335,186 | 9,479 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,149,376 | 9,622 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,701,782 | 9,574 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $2,712,804 | 9,716 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,661,335 | 11,752 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,102,919 | 11,905 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,086,911 | 12,684 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,048,727 | 12,958 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,462,448 | 12,178 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,498,578 | 12,147 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $3,312,735 | 12,326 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,592,749 | 11,678 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $3,004,952 | 12,430 | Shares | Sole | 2023-08-15 | |
| 2022-12-31 | $7,049,257 | 26,840 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,439,378 | 15,259 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,568,481 | 14,667 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,484,384 | 14,409 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,910,436 | 12,937 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,541,592 | 11,952 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,153,637 | 12,938 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,238,510 | 13,016 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,899,751 | 12,612 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,780,256 | 10,939 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,770,883 | 11,748 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,436,206 | 12,017 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||